Penumbra (PEN) EBIT Growth (1y) (2015 - 2026)
Penumbra (PEN) EBIT Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 16.18% |
| 10 | Penumbra | 12.76 Bn | 12.10 Bn | 264.94 Mn | 0.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.52% |
| Mar 31, 2026 | -5.24% |
| Dec 31, 2025 | 38.48% |
| Sep 30, 2025 | 38.10% |
| Jun 30, 2025 | 150.43% |
| Mar 31, 2025 | 233.44% |
| Dec 31, 2024 | 22.11% |
| Sep 30, 2024 | 180.11% |
| Jun 30, 2024 | -552.57% |
| Mar 31, 2024 | 51.11% |
| Dec 31, 2023 | 624.79% |
| Sep 30, 2023 | 132.33% |
| Jun 30, 2023 | 12,969.78% |
| Mar 31, 2023 | 297.92% |
| Dec 31, 2022 | 112.07% |
| Sep 30, 2022 | -38.12% |
| Jun 30, 2022 | -101.35% |
| Mar 31, 2022 | -130.05% |
| Dec 31, 2021 | -2,195.53% |
| Sep 30, 2021 | 143.56% |